Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TCR2 Therapeutics Inc.

    NASDAQ: TCRR · Real-Time Price · USD
    1.48
    0.00 (0.00%)
    At close: May 31, 2023, 10:00 PM

    TCR2 Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -151.82M -99.81M
    Depreciation & Amortization
    		 3.05M 2.83M
    Stock-Based Compensation
    		 11.38M 12.27M
    Other Working Capital
    		 8.41M 2.39M
    Other Non-Cash Items
    		 26.65M 1.4M
    Deferred Income Tax
    		 -293K 99K
    Change in Working Capital
    		 9.58M 1.62M
    Operating Cash Flow
    		 -101.46M -81.6M
    Capital Expenditures
    		 -15.45M -11.45M
    Cash Acquisitions
    		 15.45M 351K
    Purchase of Investments
    		 -267.52M -50.73M
    Sales Maturities Of Investments
    		 194.49M 140.62M
    Other Investing Acitivies
    		 -15.45M -351K
    Investing Cash Flow
    		 -88.49M 78.45M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 125K 132.14M
    Financial Cash Flow
    		 125K 132.14M
    Net Cash Flow
    		 -189.82M 128.98M
    Free Cash Flow
    		 -116.91M -93.05M

    Add to Watchlist